73 research outputs found
Genetic Organization of Acquired Antimicrobial Resistance Genes and Detection of Resistance-Mediating Mutations in a Gallibacterium anatis Isolate from a Calf Suffering from a Respiratory Tract Infection
Gallibacterium (G.) anatis isolates associated with respiratory diseases in calves and harboring acquired antimicrobial resistance genes have been described in Belgium. The aim of this study was to analyze the genetic organization of acquired resistance genes in the G. anatis isolate IMT49310 from a German calf suffering from a respiratory tract infection. The isolate was submitted to antimicrobial susceptibility testing, and a closed genome was obtained by a hybrid assembly of Illumina MiSeq short-reads and MinION long-reads. Isolate IMT49310 showed elevated MIC values for macrolides, aminoglycosides, florfenicol, tetracyclines, and trimethoprim/sulfamethoxazole. The acquired resistance genes catA1, floR, aadA1, aadB, aphA1, strA, tet(M), tet(B), erm(B), and sul2 were identified within three resistance gene regions in the genome, some of which were associated with IS elements, such as ISVsa5-like or IS15DII. Furthermore, nucleotide exchanges within the QRDRs of gyrA and parC, resulting in amino acid exchanges S83F and D87A in GyrA and S80I in ParC, were identified. Even if the role in the pathogenesis of respiratory tract infections in cattle needs to be further investigated, the identification of a G. anatis isolate with reduced susceptibility to regularly used antimicrobial agents in cases of fatal bovine respiratory tract infections is worrisome, and such isolates might also act as a reservoir for antimicrobial resistance genes
Whole-Genome Sequence of the Mycoplasma (Mesomycoplasma) hyorhinis DSM 25591 Type Strain
The whole-genome sequence of the type strain Mycoplasma (Mesomycoplasma) hyorhinis DSM 25591 is reported and compared to the available sequences of the corresponding type strains from other strain collections to ascertain conformity. Knowledge of the identity of type strains is of importance for their application in standardized test systems
Kulturlandschaften Landkreis Meißen: Forschungsprojekt im Auftrag des Landratsamtes Meißen, gefördert über die Richtlinie zur Förderung der Regionalentwicklung (FR-Regio) durch den Freistaat Sachsen
„...der Landkreis Meißen zählt durch seine Lage, seine natürliche und kulturelle Vielfalt sowie seine ausgewogene Sozial- und Wirtschaftsstruktur zu den attraktivsten Regionen im Freistaat Sachsen. Reizvolle Städte und Gemeinden mit historisch bedeutsame Gebäudeensembles werden dabei eingebettet in lebenswerte und vielfältige Kulturlandschaften, die unsere Region unverwechselbar machen. Die vorliegende Forschungsarbeit der Technischen Universität Dresden dokumentiert eindrucksvoll, wie unsere abwechslungsreichen Kulturlandschaften unsere Heimat prägen und so zur regionalen Identität beitragen. Es wird aufgezeigt, dass sie mit ihren typischen Eigenarten nicht nur Teil unseres kulturellen, sondern auch unseres Naturerbes sind. Ihre Verletzbarkeit mahnt uns, mit diesen Werten verantwortungsvoll umzugehen und macht deutlich, dass deren Schutz und behutsame Nutzung als Querschnittsthema zahlreiche Lebensbereiche berührt.
Der Umgang mit den Herausforderungen des Klimawandels und der demographischen Entwicklung wird im zukünftigen Bild unserer Kulturlandschaften sichtbar werden. Mit unseren Entscheidungen und unserem Handeln von heute beeinflussen wir das Lebensumfeld unserer Kinder, Enkel und Urenkel von morgen. Das Kulturlandschaftsprojekt bietet dabei die fachlichen Grundlagen für das Treffen der richtigen Entscheidungen und die Umsetzung konkreter Maßnahmen u. a. zum Klimaschutz, zur nachhaltigen Nutzung unserer Ressourcen und zum Erhalt unseres Kultur- und Naturerbes in den nächsten Jahrzehnten.
Allen Personen, die zum Gelingen des Kulturlandschaftsprojektes im Landkreis Meißen beigetragen haben, danke ich für ihr Engagement. Mein besonderer Dank und meine Anerkennung für das Kompendium der Kulturlandschaftsentwicklung gelten dem Team von wissenschaftlichen Mitarbeiterinnen und Mitarbeitern sowie Studentinnen und Studenten rund um Frau Prof. Dr. Catrin Schmidt und natürlich ihr selbst für ihre hochgeschätzte, fundierte Arbeit.”
Ralf Hänsel
Landra
Antimicrobial and Biocide Resistance among Canine and Feline Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii Isolates from Diagnostic Submissions
A total of 215 isolates from infections of dogs and cats, including 49 Enterococcus faecalis, 37 Enterococcus faecium, 59 Escherichia coli, 56 Pseudomonas aeruginosa, and 14 Acinetobacter baumannii, were investigated for their susceptibility to 27 (Gram-positive bacteria) or 20 (Gram-negative bacteria) antimicrobial agents/combinations of antimicrobial agents by broth microdilution according to the recommendations of the Clinical and Laboratory Standards Institute. Moreover, all isolates were analysed for their susceptibility to the biocides benzalkonium chloride, chlorhexidine, polyhexanide, and octenidine by a recently published broth microdilution biocide susceptibility testing method. While the E. faecalis isolates did not show expanded resistances, considerable numbers of the E. faecium isolates were resistant to penicillins, macrolides, tetracyclines, and fluoroquinolones. Even a single vancomycin-resistant isolate that carried the vanA gene cluster was detected. Expanded multiresistance phenotypes were also detected among the E. coli isolates, including a single carbapenem-resistant, blaOXA-48-positive isolate. In addition, multiresistant A. baumannii isolates were detected. The minimal inhibitory concentrations of the biocides showed unimodal distributions but differed with respect to the biocide and the bacterial species investigated. Although there were no indications of a development of biocide resistance, some P. aeruginosa isolates exhibited benzalkonium MICs higher than the highest test concentration
Lactobacillus Acidophilus/Bifidobacterium Infantis Probiotics Are Beneficial to Extremely Low Gestational Age Infants Fed Human Milk
To evaluate the nutrition-related effects of prophylactic Lactobacillus acidophilus/
Bifidobacterium infantis probiotics on the outcomes of preterm infants <29 weeks of gestation that
receive human milk and/or formula nutrition. We hypothesize that human-milk-fed infants benefit
from probiotics in terms of sepsis prevention and growth. Methods: We performed an observational
study of the German Neonatal Network (GNN) over a period of six years, between 1 January, 2013
and 31 December, 2018. Prophylactic probiotic use of L. acidophilus/B. infantis was evaluated in preterm
infants <29 weeks of gestation (n = 7516) in subgroups stratified to feeding type: (I) Exclusively
human milk (HM) of own mother and/or donors (HM group, n = 1568), (II) HM of own mother and/or
donor and formula (Mix group, n = 5221), and (III) exclusive exposure to formula (F group, n = 727).
The effect of probiotics on general outcomes and growth was tested in univariate models and adjusted
in linear/logistic regression models. Results: 5954 (76.5%) infants received L. acidophilus/B. infantisprophylactically for the prevention of necrotizing enterocolitis (NEC). Probiotic use was associated
with improved growth measures in the HM group (e.g., weight gain velocity in g/day: effect size
B = 0.224; 95% CI: 2.82–4.35; p < 0.001) but not in the F group (effect size B = −0.06; 95% CI: −3.05–0.28;
p = 0.103). The HM group had the lowest incidence of clinical sepsis (34.0%) as compared to the
Mix group (35.5%) and the F group (40.0%). Only in the Mix group, probiotic supplementation
proved to be protective against clinical sepsis (OR 0.69; 95% CI: 0.59–0.79; p < 0.001). Conclusion:
Our observational data indicate that the exposure to L. acidophilus/B. infantis probiotics may promote
growth in exclusively HM-fed infants as compared to formula-fed infants. To exert a sepsis-preventive
effect, probiotics seem to require human milk
Five Year Follow Up of Extremely Low Gestational Age Infants after Timely or Delayed Administration of Routine Vaccinations
This study is aimed at detecting the rate of untimely immunization in a large cohort
of extremely low gestational age neonates (ELGANs) of the German Neonatal Network (GNN)
and at addressing risk factors for delayed vaccination and associated long-term consequences. We
performed an observational study of the GNN between 1st January 2010 and 31st December 2019.
The immunization status for the hexavalent and pneumococcal immunization was evaluated in
n = 8401 preterm infants <29 weeks of gestation. Univariate analysis and logistic/linear regression
models were used to identify risk factors for vaccination delay and outcomes at a 5-year follow-up.
In our cohort n = 824 (9.8%) ELGANs did not receive a timely first immunization with the hexavalent
and pneumococcal vaccine. Risk factors for delayed vaccination were SGA status (18.1% vs. 13.5%;
OR 1.3; 95% CI: 1.1–1.7), impaired growth and surrogates for complicated clinical courses (i.e.,
need for inotropes, necrotizing enterocolitis). At 5 years of age, timely immunized children had
a lower risk of bronchitis (episodes within last year: 27.3% vs. 37.7%; OR 0.60, 95% CI: 0.42–0.86)
but spirometry measures were unaffected. In conclusion, a significant proportion of ELGANs
are untimely immunized, specifically those with increased vulnerability, even though they might
particularly benefit from the immune-promoting effects of a timely vaccination
Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase
Objective To investigate the role of neuroinflammation in asymptomatic and symptomatic amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) mutation carriers. Methods The neuroinflammatory markers chitotriosidase 1 (CHIT1), YKL-40 and glial fibrillary acidic protein (GFAP) were measured in cerebrospinal fluid (CSF) and blood samples from asymptomatic and symptomatic ALS/FTD mutation carriers, sporadic cases and controls by ELISA. Results CSF levels of CHIT1, YKL-40 and GFAP were unaffected in asymptomatic mutation carriers (n=16). CHIT1 and YKL-40 were increased in gALS (p<0.001, n=65) whereas GFAP was not affected. Patients with ALS carrying a CHIT1 polymorphism had lower CHIT1 concentrations in CSF (-80%) whereas this polymorphism had no influence on disease severity. In gFTD (n=23), increased YKL-40 and GFAP were observed (p<0.05), whereas CHIT1 was nearly not affected. The same profile as in gALS and gFTD was observed in sALS (n=64/70) and sFTD (n=20/26). CSF and blood concentrations correlated moderately (CHIT1, r=0.51) to weak (YKL-40, r=0.30, GFAP, r=0.39). Blood concentrations of these three markers were not significantly altered in any of the groups except CHIT1 in gALS of the Ulm cohort (p<0.05). Conclusion Our data indicate that neuroinflammation is linked to the symptomatic phase of ALS/FTD and shows a similar pattern in sporadic and genetic cases. ALS and FTD are characterised by a different neuroinflammatory profile, which might be one driver of the diverse presentations of the ALS/FTD syndrome
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
Patients with corticosteroid-refractory acute graft-versus-host disease (aGVHD) have a low one-year survival rate. Identification and validation of novel targetable kinases in patients who experience corticosteroid-refractory-aGVHD may help improve outcomes. Kinase-specific proteomics of leukocytes from patients with corticosteroid-refractory-GVHD identified rho kinase type 1 (ROCK1) as the most significantly upregulated kinase. ROCK1/2 inhibition improved survival and histological GVHD severity in mice and was synergistic with JAK1/2 inhibition, without compromising graft-versus-leukemia-effects. ROCK1/2-inhibition in macrophages or dendritic cells prior to transfer reduced GVHD severity. Mechanistically, ROCK1/2 inhibition or ROCK1 knockdown interfered with CD80, CD86, MHC-II expression and IL-6, IL-1β, iNOS and TNF production in myeloid cells. This was accompanied by impaired T cell activation by dendritic cells and inhibition of cytoskeletal rearrangements, thereby reducing macrophage and DC migration. NF-κB signaling was reduced in myeloid cells following ROCK1/2 inhibition. In conclusion, ROCK1/2 inhibition interferes with immune activation at multiple levels and reduces acute GVHD while maintaining GVL-effects, including in corticosteroid-refractory settings
Search for dark matter produced in association with bottom or top quarks in √s = 13 TeV pp collisions with the ATLAS detector
A search for weakly interacting massive particle dark matter produced in association with bottom or top quarks is presented. Final states containing third-generation quarks and miss- ing transverse momentum are considered. The analysis uses 36.1 fb−1 of proton–proton collision data recorded by the ATLAS experiment at √s = 13 TeV in 2015 and 2016. No significant excess of events above the estimated backgrounds is observed. The results are in- terpreted in the framework of simplified models of spin-0 dark-matter mediators. For colour- neutral spin-0 mediators produced in association with top quarks and decaying into a pair of dark-matter particles, mediator masses below 50 GeV are excluded assuming a dark-matter candidate mass of 1 GeV and unitary couplings. For scalar and pseudoscalar mediators produced in association with bottom quarks, the search sets limits on the production cross- section of 300 times the predicted rate for mediators with masses between 10 and 50 GeV and assuming a dark-matter mass of 1 GeV and unitary coupling. Constraints on colour- charged scalar simplified models are also presented. Assuming a dark-matter particle mass of 35 GeV, mediator particles with mass below 1.1 TeV are excluded for couplings yielding a dark-matter relic density consistent with measurements
Measurement of the W boson polarisation in events from pp collisions at = 8 TeV in the lepton + jets channel with ATLAS
- …